Scharen-Guivel Hilda Frederique sold $168K of IRMD
Scharen-Guivel Hilda Frederique sold 1,766 shares of IRADIMED CORP (IRMD) at $95.00 ($0.17M total) on 2026-06-04.
How this was made
The 30-second read
Why it matters
The disclosure may influence trader sentiment around IRMD but does not change the company’s fundamentals by itself.
Market read
Use as a sentiment/positioning input rather than a standalone catalyst.
What to watch
Sale size is small relative to typical company float; without follow-on filings or pattern, signal-to-noise is limited.
Background
The article reports an SEC Form 4 insider transaction by a director of IRADIMED CORP (IRMD).
Ticker impact
Director sold 1,766 shares in an open-market transaction on 2026-06-04 at $95.00/share, disclosed via SEC Form 4.
Low-to-moderate short-term negative bias; likely limited follow-through absent other catalysts.
The filing is a disclosed ownership change (not a corporate action) and provides no new operating/financial information; impact depends on whether the sale is interpreted as non-routine.
Market effects
No clear sector read-through from a single director sale without additional company/industry news.
None indicated.
None indicated.
Counterpoint
A non-10b5-1 sale can reflect diversification, taxes, or liquidity needs rather than bearish fundamentals.
Key entities
- issuerIRADIMED CORP
Subject of the SEC Form 4 insider sale disclosure.
- directorScharen-Guivel Hilda Frederique
Director who sold 1,766 shares on 2026-06-04.
